Taken together, the data suggest that PRKCQ‐AS1 overexpression in MYCN‐nonamplified neuroblastoma cells is due to a transcriptional super‐enhancer, and that PRKCQ, in contrast, is not significantly regulated by transcriptional super‐enhancers. Here, PRKCQ is linked to neuroblastoma.